GRTSQ — Gritstone bio Share News
0.000.00%
Last trade - 00:00- $0.00m
- -$15.21m
- $16.34m
Brief: Gritstone bio Q3 basic EPS USD -0.33
Brief: Gritstone Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Gritstone bio Inc expected to post a loss of 33 cents a share - Earnings Preview
Brief: HHS Project Nextgen Selects Initial Vaccine Candidates And Awards Over $500 Million To Advance Development Of Vaccines And Therapeutics
U.S. STOCKS ON THE MOVE-General Electric, Nike, Dell Technologies
U.S. STOCKS ON THE MOVE-Workday, Amazon, Accenture
U.S. STOCKS ON THE MOVE-Bolt Biotherapeutics, Sunnova, Jabil
U.S. STOCKS ON THE MOVE-Peloton, SPI Energy, Bionomics
Gritstone bio jumps on $433 million US contract for COVID vaccine study
U.S. RESEARCH ROUNDUP-Digitalbridge Group, Huntington Ingalls Industries, Workday
Gritstone bio rises on $433 mln US contract for COVID vaccine study
Gritstone bio wins $433 million US contract for COVID vaccine study (updated)
Gritstone bio wins $433 million US award for COVID vaccine study
Brief: Gritstone Bio Look Forward To Initiating Phase 2B Study (Coral-Barda) In Q1 2024
Brief: Gritstone Bio And Genevant Sciences Announce Option And License Agreement
Gritstone bio Inc expected to post a loss of 35 cents a share - Earnings Preview
Moderna/Merck begins late-stage study of skin cancer vaccine combination (updated)
Brief: Gritstone Bio Announces Interim Results From Phase 1 SAMRNA COVID-19 Vaccine Study
Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna data (updated)